Clareo Health | A Study of Avastin (Bevacizumab) in Combination With Platinum-Containing Chemotherapy in Patients With Advanced or Recurrent Non-Squamous Cell Lung Cancer.
A Study of Avastin (Bevacizumab) in Combination With Platinum-Containing Chemotherapy in Patients With Advanced or Recurrent Non-Squamous Cell Lung Cancer.
Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Hoffmann-La Roche
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
adult patients, \>=18 years of age;
histologically or cytologically documented inoperable, locally advanced ( stage III), metastatic (stage IV) or recurrent NSCLC other than squamous cell (tumors of mixed histology should be categorized by the predominant cell type);
ECOG PS status 0-2;
life expectancy \>= 12weeks;
adequate renal, liver and hematological function.
You may not be if
mixed, non-small and small cell tumors, or mixed adenosquamous carcinomas with a predominant squamous component;
hemoptysis (\>=1/2 teaspoon of bright red blood) in previous 3 months;
evidence of tumor invading major blood vessels on imaging;
evidence of CNS metastases, even if previously treated.
major surgery (including open biopsy), significant traumatic injury within 28 days prior to enrolment, or anticipation of need for major surgery during study treatment;
